# Cullinan Therapeutics, Inc.: Form 8-K, filed May 25, 2023

- Company: [Cullinan Therapeutics, Inc.](/companies/cgem.md) (CIK 1789972)
- Form: 8-K
- Filed: 2023-05-25
- Accepted by EDGAR: May 25, 2023, 17:05 ET
- Period: 2023-05-25
- Accession: 0001193125-23-154347
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1789972/000119312523154347/d462773d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1789972/000119312523154347/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1789972/000119312523154347/d462773d8k.htm

Filed May 25, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-154347. Last ingested by Listed: Nov 10, 2026, 16:50 ET. No prices; not investment advice.